rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-6-29
|
pubmed:abstractText |
Combined treatment with anti-thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves' disease. We compared methimazole (MMI) treatment with MMI + KI treatment in terms of rapid normalization of thyroid hormones during the early phase and examined the later induction of disease remission.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1365-2265
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
845-50
|
pubmed:meshHeading |
pubmed-meshheading:19912243-Adult,
pubmed-meshheading:19912243-Antithyroid Agents,
pubmed-meshheading:19912243-Drug Administration Schedule,
pubmed-meshheading:19912243-Drug Therapy, Combination,
pubmed-meshheading:19912243-Female,
pubmed-meshheading:19912243-Graves Disease,
pubmed-meshheading:19912243-Humans,
pubmed-meshheading:19912243-Male,
pubmed-meshheading:19912243-Methimazole,
pubmed-meshheading:19912243-Middle Aged,
pubmed-meshheading:19912243-Potassium Iodide,
pubmed-meshheading:19912243-Remission Induction,
pubmed-meshheading:19912243-Risk Assessment,
pubmed-meshheading:19912243-Thyroid Function Tests,
pubmed-meshheading:19912243-Thyroid Hormones,
pubmed-meshheading:19912243-Thyrotoxicosis,
pubmed-meshheading:19912243-Time Factors,
pubmed-meshheading:19912243-Treatment Outcome,
pubmed-meshheading:19912243-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
|
pubmed:affiliation |
Kuma Hospital, Kobe, Japan. takata@kuma-h.or.jp
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|